pembrolizumab
merck
['s1512', 'melanoma', 'pembro']
dr. kari kendra sharing the 89% orr (check out that waterfall) in first line pembrolizumab in unresectable desmoplastic melanoma s1512 very proud to be a part of this work #aacr23 
UCLA Postdoc, PICI and V Foundation Bridge Fellow,CRI Irvington Fellow, AACR Associate Member Council, studying cancer genomics and immunotherapies in melanoma.